BUCOLO, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 14.341
EU - Europa 7.997
AS - Asia 7.371
SA - Sud America 1.361
AF - Africa 876
Continente sconosciuto - Info sul continente non disponibili 593
OC - Oceania 17
Totale 32.556
Nazione #
US - Stati Uniti d'America 13.779
SG - Singapore 3.689
IT - Italia 2.402
RU - Federazione Russa 2.204
CN - Cina 1.977
BR - Brasile 1.125
IE - Irlanda 1.030
UA - Ucraina 864
VN - Vietnam 599
CA - Canada 406
CI - Costa d'Avorio 405
FR - Francia 364
DE - Germania 277
KR - Corea 232
GB - Regno Unito 179
NG - Nigeria 161
BD - Bangladesh 156
IN - India 147
SN - Senegal 145
SE - Svezia 133
FI - Finlandia 105
HK - Hong Kong 96
PL - Polonia 78
AR - Argentina 77
MX - Messico 76
ES - Italia 71
NL - Olanda 66
JP - Giappone 64
IQ - Iraq 58
ID - Indonesia 53
ZA - Sudafrica 51
CH - Svizzera 47
TR - Turchia 47
CO - Colombia 39
UZ - Uzbekistan 39
EC - Ecuador 38
PK - Pakistan 34
BE - Belgio 29
MA - Marocco 27
KE - Kenya 23
GR - Grecia 21
LT - Lituania 21
VE - Venezuela 21
LB - Libano 20
AE - Emirati Arabi Uniti 18
AT - Austria 18
CL - Cile 17
BJ - Benin 16
JM - Giamaica 15
JO - Giordania 15
PY - Paraguay 15
SA - Arabia Saudita 15
TN - Tunisia 15
AU - Australia 14
IR - Iran 12
CZ - Repubblica Ceca 11
HN - Honduras 11
HR - Croazia 11
PE - Perù 11
PH - Filippine 11
RO - Romania 11
UY - Uruguay 11
CR - Costa Rica 10
DZ - Algeria 9
EG - Egitto 9
EU - Europa 9
SV - El Salvador 9
AZ - Azerbaigian 8
MY - Malesia 8
NP - Nepal 8
IL - Israele 7
SY - Repubblica araba siriana 7
BG - Bulgaria 6
DK - Danimarca 6
GT - Guatemala 6
OM - Oman 6
PS - Palestinian Territory 6
PT - Portogallo 6
RS - Serbia 6
AL - Albania 5
BO - Bolivia 5
KZ - Kazakistan 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
BA - Bosnia-Erzegovina 4
BS - Bahamas 4
CY - Cipro 4
ET - Etiopia 4
HU - Ungheria 4
KG - Kirghizistan 4
NI - Nicaragua 4
BZ - Belize 3
GD - Grenada 3
MD - Moldavia 3
MK - Macedonia 3
MN - Mongolia 3
PA - Panama 3
TW - Taiwan 3
BB - Barbados 2
BH - Bahrain 2
Totale 31.926
Città #
Dallas 2.118
Singapore 2.115
Santa Clara 1.583
Chandler 1.160
Dublin 1.023
San Jose 974
Moscow 905
Jacksonville 862
Ashburn 740
Catania 638
Chicago 555
Boardman 441
Abidjan 405
Hefei 379
Beijing 287
Lauterbourg 283
Nanjing 283
Lawrence 276
Cambridge 269
Andover 267
Los Angeles 237
Toronto 237
Houston 236
Seoul 228
Ho Chi Minh City 202
New York 158
Des Moines 146
Dakar 145
Hanoi 139
Council Bluffs 134
San Mateo 126
Wilmington 121
São Paulo 103
Civitanova Marche 100
Buffalo 96
Rome 93
Palermo 91
Hong Kong 86
Grafing 82
Florence 79
Nanchang 76
Orem 76
Lagos 75
Abuja 71
Ottawa 68
Shenyang 68
Saint Petersburg 65
The Dalles 62
Hebei 61
Brooklyn 59
Messina 57
Columbus 56
Milan 55
Jiaxing 54
Warsaw 54
Bremen 53
Tokyo 53
Rio de Janeiro 50
Montreal 49
Changsha 47
Tianjin 47
Lappeenranta 46
Atlanta 42
Seattle 41
Naples 39
Munich 38
Phoenix 38
Denver 37
San Francisco 36
London 35
Aci Catena 34
Belo Horizonte 34
Washington 32
Johannesburg 31
Redwood City 31
Helsinki 29
Amsterdam 28
Dong Ket 27
Falls Church 27
Mexico City 27
Stockholm 27
Dearborn 25
Pune 25
Baghdad 24
Curitiba 24
Hangzhou 24
Belpasso 23
Redondo Beach 23
Tashkent 23
Brussels 22
Turku 22
Brasília 21
Jakarta 21
Philadelphia 21
Manchester 20
Ningbo 20
Pozzallo 20
Boston 19
Guangzhou 19
Haiphong 19
Totale 20.752
Nome #
A novel arousal-based individual screening reveals susceptibility and resilience to PTSD-like phenotypes in mice 298
Activity-Dependent Neuroprotective Protein (ADNP)-Derived Peptide (NAP) Counteracts UV-B Radiation-Induced ROS Formation in Corneal Epithelium 283
Current drug treatments targeting dopamine D3 receptor 248
Dopaminergic-GABAergic interplay and alcohol binge drinking 239
Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathway 227
Cholesterol metabolites modulate ionotropic P2X4 and P2X7 receptor current in microglia cells 219
NAP modulates hyperglycemic–inflammatory event of diabetic retina by counteracting outer blood retinal barrier damage 213
Antioxidant and osmoprotecting activity of taurine in dry eye models 197
Purine metabolism rewiring improves glioblastoma susceptibility to temozolomide treatment 195
A novel adamantane derivative attenuates retinal ischemia-reperfusion damage in the rat retina through sigma1 receptors 193
Carnosine decreases PMA-induced oxidative stress and inflammation in murine macrophages 191
Anti-VEGF agents inhibit activation of PLA2/COX-2 and expression of VEGF-A induced by high glucose, in human retinal pericytes in vitro 190
Curcumin prevents high glucose damage in retinal pigment epithelial cells through ERK1/2-mediated activation of the Nrf2/HO-1 pathway 188
The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans 187
A new human blood–retinal barrier model based on endothelial cells, pericytes, and astrocytes 186
Purinergic ionotropic P2X7 and metabotropic glutamate mGlu5 receptors crosstalk influences pro-inflammatory conditions in microglia 185
Caffeine Protects Against Retinal Inflammation 185
Activation of the VEGF-A/ERK/PLA2 axis mediates early retinal endothelial cell damage induced by high glucose: New insight from an in vitro model of diabetic retinopathy 184
Attenuation of High Glucose-Induced Damage in RPE Cells through p38 MAPK Signaling Pathway Inhibition 183
Glucose-impaired Corneal Re-epithelialization Is Promoted by a Novel Derivate of Dimethyl Fumarate 182
Buspirone counteracts MK-801-induced schizophrenia-like phenotypes through dopamine D3receptor blockade 181
Sulodexide prevents activation of the PLA2/COX-2/VEGF inflammatory pathway in human retinal endothelial cells by blocking the effect of AGE/RAGE 180
Apixaban enhances vasodilatation mediated by protease-activated receptor 2 in isolated rat arteries 177
Blood-retinal barrier protection against high glucose damage: The role of P2X7 receptor 167
A water-soluble carbon monoxide-releasing molecule (CORM-3) lowers intraocular pressure in rabbits 166
Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy 166
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 166
Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery 164
The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice 164
Melatonin loaded hybrid nanomedicine: DoE approach, optimization and in vitro study on diabetic retinopathy model 161
Retinal pharmacodynamic and pharmacokinetic profile of cannabidiol in an in vivo model of retinal excitotoxicity 160
Effects of Novel Nitric Oxide-Releasing Molecules against Oxidative Stress on Retinal Pigmented Epithelial Cells 160
Blockade of P2X7 receptors preserves blood retinal barrier integrity by modulating the plasmalemma vesicle-associated protein: Implications for diabetic retinopathy 159
Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway 159
Anti-angiogenic and antioxidant effects of axitinib in human retinal endothelial cells: implications in diabetic retinopathy 157
1α,25-dihydroxyvitamin D3 protects retinal ganglion cells in glaucomatous mice 155
Behavioral and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant 151
Efficacy and Safety of Subthreshold Micropulse Yellow Laser for Persistent Diabetic Macular Edema After Vitrectomy: A Pilot Study 149
LATE-ONSET OCULAR HYPERTENSION AFTER VITRECTOMY: A Multicenter Study of 6,048 Eyes 147
Epiretinal Membrane Vitrectomy With and Without Intraoperative Intravitreal Dexamethasone Implant: A Systematic Review With Meta-Analysis 147
Retinal Protection of New Nutraceutical Formulation 144
Carnosol attenuates high glucose damage in human retinal endothelial cells through regulation of ERK/Nrf2/HO-1 pathway 144
Fluoxetine Protects Retinal Ischemic Damage in Mice 143
Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7 143
Controversies in Glaucoma: Current Medical Treatment and Drug Development 142
Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation 142
Prognostic significance of deregulated microRNAs in uveal melanomas 142
Corneal wound healing and nerve regeneration by novel ophthalmic formulations based on cross-linked sodium hyaluronate, taurine, vitamin B6, and vitamin B12 141
Tgf-β serum levels in diabetic retinopathy patients and the role of anti-vegf therapy 141
Comparative Safety of Bevacizumab, Ranibizumab, and Aflibercept for Treatment of Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Network Meta-Analysis of Direct Comparative Studies 140
A prolonged release polymeric nanocarrier for ocular administration 139
Fingolimod and Diabetic Retinopathy: A Drug Repurposing Study 138
Carnosine Counteracts the Molecular Alterations Aβ Oligomers-Induced in Human Retinal Pigment Epithelial Cells 137
Omega-3 Fatty Acids and Depression: Scientific Evidence and Biological Mechanisms 137
Influence of trace elements on neurodegenerative diseases of the eye—the glaucoma model 137
Corneal protective effects of a new ophthalmic formulation based on vitamin B12 and sodium hyaluronate 136
Effects of novel hybrids of caffeic acid phenethyl ester and NSAIDs on experimental ocular inflammation 136
Brimonidine is Neuroprotective in Animal Paradigm of Retinal Ganglion Cell Damage 136
Acidic mammalian chitinase in dry eye conditions 134
Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticles. 134
Dopamine D-3 receptor as a new pharmacological target for the treatment of depression 134
Pericyte-like differentiation of human adipose-derived mesenchymal stem cells: An in vitro study 133
Dihydrotanshinone, a natural diterpenoid, preserves blood-retinal barrier integrity via p2x7 receptor 133
Modulation of pro-oxidant and pro-inflammatory activities of m1 macrophages by the natural dipeptide carnosine 132
Vitamin D3 preserves blood retinal barrier integrity in an in vitro model of diabetic retinopathy 131
Ocular pharmacological profile of hydrocortisone in dry eye disease 131
Assessment of a new nanostructured microemulsion system for ocular delivery of sorafenib to posterior segment of the eye 131
Topical ocular delivery of TGF-β1 to the back of the eye: Implications in age-related neurodegenerative diseases 130
Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam 129
Retinal protection and distribution of curcumin in vitro and in vivo 129
New Brilliant Blue G Derivative as Pharmacological Tool in Retinal Surgery 128
Dopamine D3 receptor is necessary for ethanol consumption: an approach with buspirone 128
"In Vivo" Evaluation of Biocompatibility and Biodegradation of Different Hyaluronan Derivatives Intravitreal Implants with Ultrasound Biomicroscopy. 127
Novel therapeutics in glaucoma management 127
The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology 125
Carnosine protects macrophages against the toxicity of aβ1-42 oligomers by decreasing oxidative stress 125
MicroRNAs in the vitreous humor of patients with retinal detachment and a different grading of proliferative vitreoretinopathy: A pilot study 123
Genetic blockade of the dopamine D3 receptor enhances hippocampal expression of PACAP and receptors and alters their cortical distribution 122
P2X7 receptor antagonism: implications in diabetic retinopathy 122
Novel ophthalmic formulation of myriocin: implications in retinitis pigmentosa 121
Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation 120
Acidic Mammalian chitinase and the eye: implications for ocular inflammatory diseases. 120
Isolation, cultivation, and characterization of primary bovine cochlear pericytes: A new in vitro model of stria vascularis 120
PACAP Modulates Expression of Hypoxia-Inducible Factors in Streptozotocin-Induced Diabetic Rat Retina 119
Retinal and Circulating miRNAs in Age-Related Macular Degeneration: An In vivo Animal and Human Study 119
Resolvin D1 attenuates the inflammatory process in mouse model of LPS-induced keratitis 119
Do extracellular RNAs provide insight into uveal melanoma biology? 119
Drug-Repurposing Strategy for Dimethyl Fumarate 118
Circulating miRNAs in diabetic retinopathy patients: Prognostic markers or pharmacological targets? 118
Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach 118
Synthesis, in vitro and in silico studies of HO-1 inducers and lung antifibrotic agents 117
The immune system on the TRAIL of Alzheimer’s disease 117
From Molecular Biology to Novel Immunotherapies and Nanomedicine in Uveal Melanoma 116
Integrating network pharmacology: The next-generation approach in ocular drug discovery 115
Effects of Vitamin D3 and Meso-Zeaxanthin on Human Retinal Pigmented Epithelial Cells in Three Integrated in vitro Paradigms of Age-Related Macular Degeneration 115
From Preformulative Design to in Vivo Tests: A Complex Path of Requisites and Studies for Nanoparticle Ocular Application. Part 2: In Vitro, Ex Vivo, and In Vivo Studies 114
Effects of Cloricromene, a Coumarin Derivative, on Rabbit Dry Eye Model 113
Novel indole derivatives targeting HuR-mRNA complex to counteract high glucose damage in retinal endothelial cells 113
Davunetide (NAP) Protects the Retina Against Early Diabetic Injury by Reducing Apoptotic Death 112
Multidisciplinary Approach to the Diagnosis and In-Hospital Management of COVID-19 Infection: A Narrative Review 111
Totale 15.089
Categoria #
all - tutte 109.869
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.869


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.905 0 277 44 32 304 58 317 92 210 38 71 462
2022/20233.662 316 175 54 374 395 597 37 617 856 46 131 64
2023/20241.587 117 230 87 106 83 326 27 118 12 25 275 181
2024/20256.433 81 996 324 319 1.339 725 324 274 552 572 464 463
2025/202613.935 811 734 2.456 851 2.027 2.571 1.602 342 706 773 707 355
2026/2027616 518 98 0 0 0 0 0 0 0 0 0 0
Totale 32.556